sEphB4-HSA

· Vasgene Therapeutics, Inc

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for sEphB4-HSA, covering 2022-04-27 to 2025-06-05. Get the full timeline:

Most recent: Clinical Trial Update: Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors [Phase 2]